Salesforce.com vs. Pegasystems: Which Customer Relationship Management Stock is the Better Buy?

NYSE: CRM | Salesforce.com Inc News, Ratings, and Charts

CRM – Companies are spending more on CRM software due to its effectiveness in increasing sales, conversions, and customer loyalty. Salesforce.com (CRM) and Pegasystems (PEGA) are two of the top stocks but which is the better buy.

At one time, only a small number of companies were investing in customer relationship management (CRM) software. However, it’s proven to be so effective in terms of increasing revenue, revenue retention, and customer satisfaction that it’s increasingly becoming a necessity.

 

They can be great investment options as these software programs can quickly become enmeshed into the company’s operations which leads to consistent revenue and opportunities to increase monetization with new features.
 
Dig through the CRM stocks for yourself and you are likely to find a couple that shines particularly bright. Below, we provide a look at two of the industry’s elite in Salesforce.com (CRM) and Pegasystems (PEGA).
 
CRM

CRM, the industry trailblazer in on-demand software for customer relationship management, has been in business since the late 90s. Based in the tech haven of San Francisco, CRM’s software really does empower organizations to manage essential operations that much more efficiently. In fact, CRM is the top CRM provider in the entire world. Gartner reports CRM’s market share is currently hovering around the 20% mark. The next closest competitor is SAP with a market share of less than 10%.

CRM has a forward P/E ratio of 63.19. This high ratio is a sign CRM might be overvalued at $239 and change per share. The stock’s 52-week high is $284.50. CRM has a 52-week low of $184.38.

CRM has a B POWR Rating grade. The stock has B grades in the Quality and Sentiment components of the POWR Ratings. The stock has Cs in the Value and Momentum components. You can find out how CRM fares in the Growth and Stability components of the POWR Ratings by clicking here.

Of the 131 publicly traded companies in the Software – Application space, CRM is ranked 24th. Investors who are interested in learning more about the stocks that comprise this sector can do so by clicking here.

The top analysts insist CRM has considerable upside potential, setting an average target price of $278.66. If CRM reaches this price, it will have popped by more than 14%. Across the prior 13 months, the average analyst price target for the stock has increased nearly $82. Of the 47 analysts to have issued CRM recommendations, 14 consider it a Strong Buy, 23 consider it a Buy, and 10 consider it a Hold.

PEGA

PEGA, a global trailblazer in the CRM field, specializes in CRM software that empowers organizations to manage extensive customer interactions. PEGA’s software makes it easier for businesses to provide the best possible customer service across a litany of channels. PEGA customers are in myriad industries including healthcare management, insurance, telecommunications, and financial services.

PEGA’s current price point of $134.60 is concerning as the stock has a forward P/E ratio of 482.43. This is an absurdly high ratio. However, PEGA qualifies as a tech stock so plenty of investors will overlook the potential overvaluation and hop on board. PEGA has a beta of 1.20, meaning it is unlikely to significantly undulate should the market get rocky. The stock is currently trading about $14 below its 52-week high of $148.80. PEGA’s 52-week low is $100.69.

PEGA has a C rating meaning it is a Hold. The stock has a B Sentiment grade yet it has Cs in POWR Ratings components such as Stability, Quality, and Momentum. You can find out how PEGA fares in the rest of the POWR Ratings grades such as Value and Growth by clicking here.

PEGA is ranked 24th out of 59 stocks in its Software – Business category. You can find out more about the stocks in this space by clicking here.

The top analysts have established an average price target of $162.33 for PEGA. This means PEGA has 22% upside potential. The stock’s highest target price is $180. The lowest analyst target price for PEGA is $162.33.

Which is the Better Buy?

CRM is the better buy as it has a superior POWR Rating. There is the potential for PEGA to ascend from its C POWR Rating to a B or A rating in due time yet the stock is not worth investing in at the current moment. Roll with CRM and you will sleep soundly at night.


CRM shares were trading at $241.96 per share on Wednesday morning, up $1.85 (+0.77%). Year-to-date, CRM has gained 8.73%, versus a 16.77% rise in the benchmark S&P 500 index during the same period.


About the Author: Patrick Ryan


Patrick Ryan has more than a dozen years of investing experience with a focus on information technology, consumer and entertainment sectors. In addition to working for StockNews, Patrick has also written for Wealth Authority and Fallon Wealth Management. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
CRMGet RatingGet RatingGet Rating
PEGAGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

1 Big Reason Stocks Should Be Soaring Higher

We are entering the heart of earnings season so now is a good time to check in and see how the early reports look and what that means for the stock market outlook (SPY). Spoiler Alert: It looks very bullish. Read on for full details below…

:  |  News, Ratings, and Charts

3 Dividend-Paying Healthcare Stocks Thriving With Lower Rates

Investors should consider adding dividend-paying stocks in the healthcare sector to their portfolios given the drop in rates and rising coronavirus concerns. 3 of the top dividend-paying healthcare stocks are Johnson & Johnson (JNJ), AbbVie Inc. (ABBV), and Unitedhealth Group (UNH).   

:  |  News, Ratings, and Charts

Why Do Most Investors Fail?

Most individual investors underperform the stock market (SPY). Sadly 85% of mutual fund managers also come up short of the mark. So what does work? Quant investing which now makes up more than 50% of daily trading activity. However, these method seem out of reach for most investors. That is all about to change as I will show 5 ways to apply quant investing models to help you beat the market going forward. Read on for more...

:  |  News, Ratings, and Charts

Scathing Allegations Should Make Investors Nervous About Coinbase

Cathie Wood might like Coinbase (COIN) stock, but informed investors should be cautious as a class-action lawsuit pokes holes in Coinbase's reputation.

:  |  News, Ratings, and Charts

Why Do Most Investors Fail?

Most individual investors underperform the stock market (SPY). Sadly 85% of mutual fund managers also come up short of the mark. So what does work? Quant investing which now makes up more than 50% of daily trading activity. However, these method seem out of reach for most investors. That is all about to change as I will show 5 ways to apply quant investing models to help you beat the market going forward. Read on for more...

Read More Stories

More Salesforce.com Inc (CRM) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CRM News